FDA Inspection 1326732 — Bloodworks
The FDA completed an inspection of Bloodworks on July 15, 2026 in Lynnwood, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lynnwood, WA (United States)